RC, G., RC, K., RN, M., JD, M., L, E., WM, T., . . . RP, L. (2022). Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: Comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model. Drug delivery and translational research, 12(5), 1105. https://doi.org/10.1007/s13346-021-00985-8
Chicago Style (17th ed.) CitationRC, Gaba, et al. "Conventional Versus Drug-eluting Embolic Transarterial Chemoembolization with Doxorubicin: Comparative Drug Delivery, Pharmacokinetics, and Treatment Response in a Rabbit VX2 Tumor Model." Drug Delivery and Translational Research 12, no. 5 (2022): 1105. https://doi.org/10.1007/s13346-021-00985-8.
MLA (9th ed.) CitationRC, Gaba, et al. "Conventional Versus Drug-eluting Embolic Transarterial Chemoembolization with Doxorubicin: Comparative Drug Delivery, Pharmacokinetics, and Treatment Response in a Rabbit VX2 Tumor Model." Drug Delivery and Translational Research, vol. 12, no. 5, 2022, p. 1105, https://doi.org/10.1007/s13346-021-00985-8.